Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Merit Medical Systems, Inc.NASDAQ: MMSI
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization grows in line with its trailing trend
Q3 FY2026 depreciation & amortization of $34.84M rose 1.7% year over year, behind the +3.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.6% from the prior quarter. Over 3 fiscal years it compounded at +13.5% a year.
Context
- Depreciation & amortization amounted to 8.9% of revenue in FY2025, up 0.4 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +1.7% toward the trailing-twelve-month pace of +3.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 134.65M USD
- Year-over-year change
- +17.4%
- 4-year CAGR
- +8.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 134.65M | +17.4% |
| FY2024 | 2024-12-31 | 114.73M | +13.3% |
| FY2023 | 2023-12-31 | 101.29M | +9.9% |
| FY2022 | 2022-12-31 | 92.2M | -3.7% |
| FY2021 | 2021-12-31 | 95.78M | — |
Depreciation & Amortization vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 depreciation & amortization of $136.48M is the 6th largest of the 10 companies compared; the peer median is $181.49M.
- Its year-over-year change of +3.5% is the 4th highest of 10, against a peer median of -4.2%.
- Depreciation & amortization amounts to 8.5% of revenue for MMSI, versus a peer median of 6.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.24B | -4.2% | -0.7% | 11.1% | |
| LTM Jun 2026 | $1.41B | +7.5% | +6.4% | 6.7% | |
| LTM Jun 2026 | $506M | -5.2% | -5.4% | 6.1% | |
| LTM Jun 2026 | $204.78M | -1.5% | -5.1% | 9.5% | |
| LTM Jun 2026 | $181.49M | -33.6% | -8.3% | 7.0% | |
| LTM Sep 2026 | $136.48M | +3.5% | +13.5% | 8.5% | |
| LTM Mar 2026 | $60.2M | -10.3% | +2.2% | 4.4% | |
| LTM Feb 2026 | $23.19M | -13.4% | -4.2% | 7.4% | |
| LTM Jun 2026 | $20.86M | +4.2% | +20.6% | 3.7% | |
| LTM Mar 2026 | $10.49M | +6.6% | +3.4% | 4.1% | |
| Peer median (excluding MMSI) | $181.49M | -4.2% | -0.7% | 6.7% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| Deferred Income Tax | (4.63M) | (14.92M) | (12.64M) | (14.87M) | 5.21M |
| Stock-Based Compensation | 16.09M | 18.04M | 21.33M | 28.47M | 43.46M |
| Change in Working Capital | (17.84M) | (71.4M) | (70.02M) | (36.95M) | (23.34M) |
| Accounts Receivables | (8.62M) | (15.12M) | (9.55M) | (21.7M) | (2.73M) |
| Inventory | (25.18M) | (47.93M) | (32.11M) | (2.29M) | (21.6M) |
| Accounts Payables | 6.05M | 12.66M | (7.3M) | (2.31M) | 1.01M |
| Other Working Capital | 9.91M | (21.01M) | (21.08M) | (10.64M) | (26K) |
| Other Non-Cash Items | 9.37M | 15.86M | 10.78M | 9.06M | 8.9M |
| Operating Cash Flow | 147.23M | 114.29M | 145.15M | 220.8M | 297.37M |
| Capital Expenditures | (27.94M) | (45.03M) | (36.7M) | (38.04M) | (84.84M) |
| Acquisitions (Net) | (7.17M) | (8.29M) | (137.85M) | (320.18M) | (144.77M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2.05M) | (4.08M) | (799K) | (10.43M) | (17.78M) |
| Investing Cash Flow | (37.16M) | (57.4M) | (175.35M) | (368.65M) | (247.39M) |
| Debt Repayment | (108.5M) | (44.94M) | 619.58M | (99.06M) | 0 |
| Common Stock Issued | 21.31M | 20.07M | 15.58M | 40.91M | 28.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (11.24M) | (35.39M) | (75.9M) | (1.85M) | (12.21M) |
| Financing Cash Flow | (98.44M) | (60.26M) | 559.27M | (60.01M) | 16M |
| Effect of Forex Changes | (801K) | (3.83M) | (484K) | (2.52M) | 3.8M |
| Net Change in Cash | 10.83M | (7.19M) | 528.59M | (210.38M) | 69.78M |
| Free Cash Flow | 119.29M | 69.26M | 108.45M | 182.76M | 212.54M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.